BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19383421)

  • 1. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
    Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L
    Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
    Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population.
    Choi JM; Kim WC; Lyoo CH; Kang SY; Lee PH; Baik JS; Koh SB; Ma HI; Sohn YH; Lee MS; Kim YJ
    Neurosci Lett; 2012 Apr; 514(1):12-5. PubMed ID: 22387070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations for Gaucher disease confer high susceptibility to Parkinson disease.
    Mitsui J; Mizuta I; Toyoda A; Ashida R; Takahashi Y; Goto J; Fukuda Y; Date H; Iwata A; Yamamoto M; Hattori N; Murata M; Toda T; Tsuji S
    Arch Neurol; 2009 May; 66(5):571-6. PubMed ID: 19433656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
    Huang CL; Wu-Chou YH; Lai SC; Chang HC; Yeh TH; Weng YH; Chen RS; Huang YZ; Lu CS
    Eur J Neurol; 2011 Oct; 18(10):1227-32. PubMed ID: 21338444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.
    Nichols WC; Pankratz N; Marek DK; Pauciulo MW; Elsaesser VE; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
    Neurology; 2009 Jan; 72(4):310-6. PubMed ID: 18987351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson's disease.
    Yu Z; Wang T; Xu J; Wang W; Wang G; Chen C; Zheng L; Pan L; Gong D; Li X; Qu H; Li F; Zhang B; Le W; Han F
    J Hum Genet; 2015 Feb; 60(2):85-90. PubMed ID: 25518742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal.
    Bras J; Paisan-Ruiz C; Guerreiro R; Ribeiro MH; Morgadinho A; Januario C; Sidransky E; Oliveira C; Singleton A
    Neurobiol Aging; 2009 Sep; 30(9):1515-7. PubMed ID: 18160183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.
    Lesage S; Anheim M; Condroyer C; Pollak P; Durif F; Dupuits C; Viallet F; Lohmann E; Corvol JC; Honoré A; Rivaud S; Vidailhet M; Dürr A; Brice A;
    Hum Mol Genet; 2011 Jan; 20(1):202-10. PubMed ID: 20947659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
    Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
    Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.
    Beavan MS; Schapira AH
    Ann Med; 2013 Dec; 45(8):511-21. PubMed ID: 24219755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
    Alcalay RN; Dinur T; Quinn T; Sakanaka K; Levy O; Waters C; Fahn S; Dorovski T; Chung WK; Pauciulo M; Nichols W; Rana HQ; Balwani M; Bier L; Elstein D; Zimran A
    JAMA Neurol; 2014 Jun; 71(6):752-7. PubMed ID: 24756352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase mutations in Thai patients with Parkinson's disease.
    Pulkes T; Choubtum L; Chitphuk S; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):986-91. PubMed ID: 24997549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.